Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
A method of providing a therapeutic effect in human patients by administering to the patient CD34+ cells obtained from umbilical cord blood. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Aug 2010 - $15,200
Jun 2010 - 108 pages - $3,800
Jul 2011 - 39 pages - $5,700
Feb 2011 - 20 pages - $99
Jul 2011 - 136 pages - $500
Feb 2011 - 42 pages - $5,700
Jul 2011 - 55 pages - $5,700
Mar 2011 - 33 pages - $5,700
Apr 2011 - 26 pages - $500
Sep 2010 - 25 pages - $2,000
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us